Renalytix Plc (RNLXY)
3.70
+0.08
(+2.17%)
USD |
OTCM |
Nov 13, 16:00
Renalytix Enterprise Value : 30.92M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 30.92M |
| November 12, 2026 | 30.23M |
| November 11, 2026 | 30.23M |
| November 10, 2026 | 30.92M |
| November 09, 2026 | 30.92M |
| November 06, 2026 | 30.92M |
| November 05, 2026 | 31.71M |
| November 04, 2026 | 31.71M |
| November 03, 2026 | 30.48M |
| November 02, 2026 | 30.48M |
| October 30, 2026 | 30.90M |
| October 29, 2026 | 29.96M |
| October 28, 2026 | 30.57M |
| October 27, 2026 | 32.23M |
| October 26, 2026 | 32.23M |
| October 23, 2026 | 32.23M |
| October 22, 2026 | 30.92M |
| October 21, 2026 | 29.87M |
| October 20, 2026 | 29.87M |
| October 19, 2026 | 29.65M |
| October 16, 2026 | 29.17M |
| October 15, 2026 | 28.21M |
| October 14, 2026 | 29.17M |
| October 13, 2026 | 28.73M |
| October 12, 2026 | 29.96M |
| Date | Value |
|---|---|
| October 09, 2026 | 28.30M |
| October 08, 2026 | 31.79M |
| October 07, 2026 | 31.79M |
| October 06, 2026 | 31.09M |
| October 05, 2026 | 31.09M |
| October 02, 2026 | 33.54M |
| October 01, 2026 | 33.54M |
| September 30, 2026 | 31.71M |
| September 29, 2026 | 32.45M |
| September 28, 2026 | 33.54M |
| September 25, 2026 | 33.54M |
| September 24, 2026 | 33.54M |
| September 23, 2026 | 35.03M |
| September 22, 2026 | 33.54M |
| September 21, 2026 | 34.85M |
| September 18, 2026 | 34.85M |
| September 17, 2026 | 34.85M |
| September 16, 2026 | 35.03M |
| September 15, 2026 | 35.03M |
| September 14, 2026 | 34.15M |
| September 11, 2026 | 35.29M |
| September 10, 2026 | 32.67M |
| September 09, 2026 | 32.19M |
| September 08, 2026 | 32.19M |
| September 04, 2026 | 34.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CompuMed, Inc. | 5.971M |
| Quest Diagnostics, Inc. | 34.44B |
| Labcorp Holdings, Inc. | 36.61B |
| Myriad Genetics, Inc. | 643.96M |
| OPKO Health, Inc. | 1.321B |
Enterprise Value Related Metrics
| Earnings Yield | -47.38% |